Alcohol-free pharmaceutical composition comprising thyme and primula root liquid extracts
YU9099A
Use of 2-phenyl-1,2-benzisoselenazol- 3(2h)-one for producing a pharmaceutical preparation intended for treatment of alzheimer’s disease
EP0826370A1
Pharmaceutical composition comprising 2-phenyl-1,2-benzoisoelenazol-3(2H)-one for the treatment of Alzheimer disease
BR9707303A
Therapeutic agents for asthma
US6663885B1
Aqueous liposome system and a method for the preparation of such a liposome system
US5741513A
Alcoholic aqueous gel-like phospholipid composition, its use and topical preparations containing it
DE19506669A1
Lipoxygenase inhibitor for treating asthma, tumours, shock etc.
US5556637A
Water containing liposome system
SG15294G
Alcoholic aqueous gel-type phospholipid composition, its use and topical preparations containing it.
IE920454A1
r3-(fl-ARYLALKYL)-2-THIENYLl-ALKAN0IC ACID, ITS SALTS AND/OR ITS DERIVATIVES
IE920455A1
[2-(O-arylalkyl)-3-thienylJ-alkanoic acids, their salts and/or their derivatives
US5288734A
Stable parenteral solution of 2-phenyl-1.2-benzisoselenazol-3(2H)-one and process for producing the same
DE4122744A1
Aqueous liposome system and process for its preparation
DE4122661A1
Pharmaceutical product for the treatment of Pneumocystis carinii pneumonia
DE4121389A1
PHARMACEUTICAL PRODUCT FOR TREATING VIRUS DISEASES
DE4121388A1
PHARMACEUTICAL PRODUCT FOR TREATING VIRUS DISEASES
DE4116656A1
New 2-(omega-aryl:alkyl)-3-thienyl-alkanoic acid derivs. - as LTB4 antagonists for treatment of eczema, psoriasis, acne arthritis, asthma, rhinitis or inflammatory intestinal disorders
DE4116655A1
New 3-(omega-arylalkyl)-2-thienyl-alkanoic acid derivs. - as LTB4 antagonists for treatment of eczema, psoriasis, acne, arthritis, asthma, rhinitis or inflammatory intestinal disorders
DE4108903A1
Aq. liposome systems
EP0629128A1
Aqueous phospholipid vesicle dispersion, process for its manufacture and use thereof
